>
pdufa.bio

Hypericin

Updated ยทnext FDA decision on the calendar

Hypericin is a Soligenix, Inc. program. Every date links its source.

SNGX catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Soligenix, Inc. (SNGX). We track 1 catalyst event for this program: 0 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · May 2026SNGX

Questions

When is Hypericin's next FDA decision or readout?

No upcoming catalyst is on our calendar for Hypericin; no FDA decisions are on record below.

What happened at Hypericin's most recent FDA decision?

No FDA decision for Hypericin is in our archive yet.

Who makes Hypericin?

Soligenix, Inc. (SNGX).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.